Urmila Kerslake
Vascular external support system use found to boost key functional outcomes...
Alik Farber, MD, professor of surgery and radiology at Boston University, is set to present the results of a multicenter U.S. study at the...
Could metformin be first-ever medical treatment that is effective at managing...
There is a global interest in assessing whether metformin, which has a long track record of safety and efficacy, is relatively inexpensive and is...
TCT 2023: First presentation of complete patient-level dataset on paclitaxel and...
Data from a patient-level meta-analysis—a factor in the Food and Drug Administration’s (FDA) recent change of position on the use of paclitaxel-coated devices to...
Long-awaited FDA update finds data do not support excess mortality risk...
In a letter to healthcare providers dated July 11, 2023, the Food and Drug Administration (FDA) communicates that the risk of mortality associated with...
Significant life and limb gains for claudicants who stop smoking before...
Long-term overall survival (OS) and amputation-free survival (AFS) are outcomes that rebound in claudicants who quit smoking prior to elective surgery—and they mirror those...
Summit dedicated to tackling key issues related to women’s vascular health...
Linda Harris, MD, is a prolific attendee on the national and regional vascular meeting circuit, a noteworthy academic vascular surgeon with trainees and papers...
Women’s Vascular Summit: Diving into issues around women’s vascular health and...
The Women’s Vascular Summit was established five years ago with the twin purposes of delving deeper into the issues that surround women’s vascular health...
First data from BEST-CLI bring surgical bypass into the forefront of...
The first results from the BEST-CLI randomized controlled trial (RCT) of 1,830 patients show that surgical bypass with adequate single-segment great saphenous vein (GSV)...
CX Aortic Vienna: Onus on industry to meet clinician desire for...
The need for vascular companies to home in on developing longer-lasting devices—perhaps even ones that adapt over time to match patients’ changing anatomies—was underscored...
Outgoing SVS president’s message of unity: ‘We must work together to...
The Society for Vascular Surgery (SVS) is no longer the organization it was half a century ago. That was one of the core messages...
New SVS president outlines priorities for his tenure as Society aims...
Michael Dalsing, MD, who took over as Society for Vascular Surgery (SVS) president at the 2022 Vascular Annual Meeting (VAM) in Boston (June 15–18),...
Greenberg Lecture raises prospect that ‘less is more and more is...
Jan S. Brunkwall, MD, from the University of Cologne in Cologne, Germany, delivered the Roy Greenberg Distinguished Lecture at the 2022 Vascular Annual Meeting...
First results from BEST-CLI poised to reveal ‘very low’ quality of...
An analysis from the Best Endovascular versus Best Surgical Therapy in Patients with Critical Limb Ischemia (BEST-CLI) trial presented at the 2022 Vascular Annual...
Houston, we have a dialysis access problem
The concept of dedicated vascular access centers fuels a turbocharged Texan tussle with Karl Illig, MD, of Flow Vascular Institute in Houston, taking on Eric...
New SVS vice president: ‘How do vascular surgeons differ? We provide...
New Society for Vascular Surgery (SVS) Vice President Joseph Mills, MD, talks to Vascular Specialist about how inclusivity is at the forefront of SVS...
New imaging technique has potential to identify patients at high risk...
Four-dimensional (4D) flow magnetic resonance imaging (MRI) has the potential to identify patients with a higher risk of severe complications from aortic degeneration, according...
Five-year STABLE II results show Zenith system makes the cut for...
Joseph V. Lombardi, MD, reported long-term outcomes favoring the continued safety and effectiveness of a composite device (proximal covered stent graft plus distal bare...
LimFlow system a ‘cost-effective and high-value alternative’ to traditional therapies
Percutaneous deep vein arterialization (pDVA) with the LimFlow system offers a cost-effective and high-value alternative to traditional therapies or amputation, according to a recent...
Just 16% of US centers in VQI offer SVS guideline-compliant open...
There is a stark downward trend in the number of U.S. centers in the Vascular Quality Initiative (VQI) that meet the Society for Vascular...
Latest meta-analysis on paclitaxel in peripheral arterial disease provokes mixed reception
“There appears to be heightened risk of major amputation after use of paclitaxel-coated balloons in the peripheral arteries,” findings from a systematic review...